Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 95 results for "sarabjit kour nangra"

Halol contributes 35-40% to Sun's US sales: Angel Broking

Speaking to CNBC-TV18 on the impact of the surprise audit on the company, Sarabjit Kour Nangra, Angel Broking advises investors not to panic and wait till the details of the audit report are released. According to Nangra, Sun's merger with Ranbaxy ... Moneycontrol.com, 1 week ago

1 images for "sarabjit kour nangra"

Rediff.com, 1 month ago

Prices of 43 More Drugs Capped

HYDERABAD: The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of 43 formulation packs including drugs such as antibiotic Ciprofloxacin, BCG vaccine and anti-diabetic Metformin. The price revision was done as per the Drug ...
 New Indian Express22 hours ago NPPA caps prices of 43 drug formulation packs  Business Standard India1 day ago 43 more drugs brought under price control  Hindu Business Line2 days ago
[x]  

Lupin joins hands with Merck Serono for emerging markets

German biopharmaceuticals company Merck Serono has found a partner in Lupin Pharma, where they would together make and market around 20 newer products of core therapeutic areas like diabetes and cardiovascular in emerging economies. The initial ...
 Financial Chronicle3 days ago Angel Broking remains neutral on Cipla and Cadila Healthcare  MyIris5 days ago Angel Broking remains neutral on Lupin  MyIris4 days ago Angel Broking remains neutral on Ranbaxy Labs  MyIris4 days ago
Business Standard India

Sun Pharma: Is the Street's nervousness justified?

The impact of Taro's recalled products is not much but any adverse regulatory action on the Halol plant will hurt Ujjval Jauhari September 12, 2014 Last Updated at 22:35 IST Sun Pharmaceutical Industries' stock, which lost 4.2 per cent on Thursday ...
 Business Standard India1 week ago

FDA's Surprise Visit To Sun Pharmaceutical Industries Ltd's Pressures Stock

September 12, 2014 By Jessica Wilson , BioSpace.com Breaking News Staff Share prices of Mumbai-based Sun Pharmaceutical Industries continued to drop Friday in the wake of reports that the U.S. Food and Drug Administration (FDA) performed a ...
 BioSpace1 week ago Sun Pharma stock price reacts on news of US FDA's surprise plant inspection  The Hindu1 week ago
Business Standard India

Sun Pharma, Ranbaxy extends fall on US FDA's surprise plant inspection

Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories have dipped up to 4% extending their previous day's fall on reports of drug regulator, US Food and Drug Administration (FDA) conducting a surprise inspection of the Sun Pharma's ...
 Smart Investor1 week ago Sun Pharma, Ranbaxy extend fall on US FDA's surprise plant inspection  Smart Investor1 week ago
DNA India

Sun tanks 6% as Halol unit comes under cloud

Shares of Sun Pharmaceutical Industries dropped over 4% on Thursday on unconfirmed reports that the US Food and Drug Administration (FDA) made a surprise inspection at its manufacturing facility at Halol in Gujarat. The scrip opened at Rs 853 on ...
 DNA India1 week ago Sun Pharma falls 4% on surprise inspection reports  Business Today India1 week ago Sun Pharma shares dip on surprise audit by USFDA at Halol plant  IndiaVision1 week ago Sun Pharma falls 6% as USFDA inspects Halol unit; facility contributes 40% of US sales  Economic Times1 week ago
[x]  
Livemint.com

Wockhardt Comeback Sets Up Indian Drugmaker as Target: Real M

(For a Real M&A column news alert: SALT REALMNA .) Sept. 4 (Bloomberg) -- For acquirers willing to look past U.S. punishments for quality and hygiene violations at two plants, Indian drugmaker Wockhardt Ltd. is offering the prospect of a return to ...
 La Repubblica2 weeks ago Wockhardt Comeback Sets Up Drugmaker as Target: Real M  Bloomberg2 weeks ago
[x]  

Growth trajectory ahead remains interesting for Cipla: Analysts

Cipla , leading drug maker, announced the launch of Serroflo, its Salmeterol/Fluticasone MDI, in Germany and Sweden. With this launch, Cipla opens the door for new, highly efficient treatments in the European healthcare market. Serroflo will substantially ...
 Myiris2 weeks ago
Business Today India

Ten bargain stocks you must invest in right now

Value investing must be the most talked about investment philosophy on the planet. One reason for this is that it can deliver good returns in all types of market situations. So, when stock markets are down in the dumps, value investors such as ...
 Business Today India1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sarabjit kour nangra
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less